ISDA

Deposition Date 2005-09-07

Release Date 2005-11-22

Last Version Date 2023-08-23

Entry Detail

PDB ID:

2AYR

Keywords:

TRANSCRIPTION

Title:

A SERM Designed for the Treatment of Uterine Leiomyoma with Unique Tissue Specificity for Uterus and Ovaries in Rats

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.90 Å

R-Value Free:

0.26

R-Value Work:

0.22

R-Value Observed:

0.23

Space Group:

P 65 2 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Estrogen receptor
Gene (Uniprot):ESR1
Mutations:C381S, C417S, C530S
Chain IDs:A
Chain Length:248
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P03372 Pfam ID:PF00104

Ligand Molecules

L4G

Primary Citation

A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats

Hummel, C.W, Geiser, A.G, Bryant, H.U, Cohen, I.R, Dally, R.D, Fong, K.C, Frank, S.A, Hinklin, R, Jones, S.A, Lewis, G, McCann, D.J, Rudman, D.G, Shepherd, T.A, Tian, H, Wallace, O.B, Wang, Y, Dodge, J.A.Show

J.Med.Chem. 48 6772 6775 (2005)

PMID: 16250633 DOI: 10.1021/jm050723z

Abstact

The design of a novel selective estrogen receptor modulator (SERM) for the potential treatment of uterine leiomyoma is described. 16 (LY2066948-HCl) binds with high affinity to estrogen receptors alpha and beta (ERalpha and ERbeta, respectively) and is a potent uterine antagonist with minimal effects on the ovaries as determined by serum biomarkers and histologic evaluation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures